img

Global B Streptococcus (GBS) Infection Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global B Streptococcus (GBS) Infection Treatment Market Research Report 2024

According to MRAResearch’s new survey, global B Streptococcus (GBS) Infection Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole B Streptococcus (GBS) Infection Treatment market research.
Key companies engaged in the B Streptococcus (GBS) Infection Treatment industry include Pfizer Inc., Alopexx Pharmaceuticals, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis and GlaxoSmithKline, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of B Streptococcus (GBS) Infection Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole B Streptococcus (GBS) Infection Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global B Streptococcus (GBS) Infection Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer Inc.
Alopexx Pharmaceuticals, LLC
Wellstat Vaccines LLC
Minervax ApS
Novartis
GlaxoSmithKline
Segment by Type
Prenatal-onset GBS Disease
Early-onset GBS Disease
Late-onset GBS Disease

Segment by Application


Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The B Streptococcus (GBS) Infection Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Prenatal-onset GBS Disease
1.2.3 Early-onset GBS Disease
1.2.4 Late-onset GBS Disease
1.3 Market by Application
1.3.1 Global B Streptococcus (GBS) Infection Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global B Streptococcus (GBS) Infection Treatment Market Perspective (2018-2033)
2.2 B Streptococcus (GBS) Infection Treatment Growth Trends by Region
2.2.1 Global B Streptococcus (GBS) Infection Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 B Streptococcus (GBS) Infection Treatment Historic Market Size by Region (2018-2023)
2.2.3 B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Region (2024-2033)
2.3 B Streptococcus (GBS) Infection Treatment Market Dynamics
2.3.1 B Streptococcus (GBS) Infection Treatment Industry Trends
2.3.2 B Streptococcus (GBS) Infection Treatment Market Drivers
2.3.3 B Streptococcus (GBS) Infection Treatment Market Challenges
2.3.4 B Streptococcus (GBS) Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top B Streptococcus (GBS) Infection Treatment Players by Revenue
3.1.1 Global Top B Streptococcus (GBS) Infection Treatment Players by Revenue (2018-2023)
3.1.2 Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Players (2018-2023)
3.2 Global B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by B Streptococcus (GBS) Infection Treatment Revenue
3.4 Global B Streptococcus (GBS) Infection Treatment Market Concentration Ratio
3.4.1 Global B Streptococcus (GBS) Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B Streptococcus (GBS) Infection Treatment Revenue in 2022
3.5 B Streptococcus (GBS) Infection Treatment Key Players Head office and Area Served
3.6 Key Players B Streptococcus (GBS) Infection Treatment Product Solution and Service
3.7 Date of Enter into B Streptococcus (GBS) Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 B Streptococcus (GBS) Infection Treatment Breakdown Data by Type
4.1 Global B Streptococcus (GBS) Infection Treatment Historic Market Size by Type (2018-2023)
4.2 Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2024-2033)
5 B Streptococcus (GBS) Infection Treatment Breakdown Data by Application
5.1 Global B Streptococcus (GBS) Infection Treatment Historic Market Size by Application (2018-2023)
5.2 Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
6.2 North America B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
6.4 North America B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
7.2 Europe B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
7.4 Europe B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
8.2 Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
9.2 Latin America B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
9.4 Latin America B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size (2018-2033)
10.2 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. B Streptococcus (GBS) Infection Treatment Introduction
11.1.4 Pfizer Inc. Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.1.5 Pfizer Inc. Recent Development
11.2 Alopexx Pharmaceuticals, LLC
11.2.1 Alopexx Pharmaceuticals, LLC Company Detail
11.2.2 Alopexx Pharmaceuticals, LLC Business Overview
11.2.3 Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Introduction
11.2.4 Alopexx Pharmaceuticals, LLC Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.2.5 Alopexx Pharmaceuticals, LLC Recent Development
11.3 Wellstat Vaccines LLC
11.3.1 Wellstat Vaccines LLC Company Detail
11.3.2 Wellstat Vaccines LLC Business Overview
11.3.3 Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Introduction
11.3.4 Wellstat Vaccines LLC Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.3.5 Wellstat Vaccines LLC Recent Development
11.4 Minervax ApS
11.4.1 Minervax ApS Company Detail
11.4.2 Minervax ApS Business Overview
11.4.3 Minervax ApS B Streptococcus (GBS) Infection Treatment Introduction
11.4.4 Minervax ApS Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.4.5 Minervax ApS Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis B Streptococcus (GBS) Infection Treatment Introduction
11.5.4 Novartis Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
11.6.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Prenatal-onset GBS Disease
Table 3. Key Players of Early-onset GBS Disease
Table 4. Key Players of Late-onset GBS Disease
Table 5. Global B Streptococcus (GBS) Infection Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global B Streptococcus (GBS) Infection Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global B Streptococcus (GBS) Infection Treatment Market Share by Region (2018-2023)
Table 9. Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global B Streptococcus (GBS) Infection Treatment Market Share by Region (2024-2033)
Table 11. B Streptococcus (GBS) Infection Treatment Market Trends
Table 12. B Streptococcus (GBS) Infection Treatment Market Drivers
Table 13. B Streptococcus (GBS) Infection Treatment Market Challenges
Table 14. B Streptococcus (GBS) Infection Treatment Market Restraints
Table 15. Global B Streptococcus (GBS) Infection Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global B Streptococcus (GBS) Infection Treatment Market Share by Players (2018-2023)
Table 17. Global Top B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Streptococcus (GBS) Infection Treatment as of 2022)
Table 18. Ranking of Global Top B Streptococcus (GBS) Infection Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by B Streptococcus (GBS) Infection Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players B Streptococcus (GBS) Infection Treatment Product Solution and Service
Table 22. Date of Enter into B Streptococcus (GBS) Infection Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global B Streptococcus (GBS) Infection Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Pfizer Inc. Company Detail
Table 48. Pfizer Inc. Business Overview
Table 49. Pfizer Inc. B Streptococcus (GBS) Infection Treatment Product
Table 50. Pfizer Inc. Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 51. Pfizer Inc. Recent Development
Table 52. Alopexx Pharmaceuticals, LLC Company Detail
Table 53. Alopexx Pharmaceuticals, LLC Business Overview
Table 54. Alopexx Pharmaceuticals, LLC B Streptococcus (GBS) Infection Treatment Product
Table 55. Alopexx Pharmaceuticals, LLC Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 56. Alopexx Pharmaceuticals, LLC Recent Development
Table 57. Wellstat Vaccines LLC Company Detail
Table 58. Wellstat Vaccines LLC Business Overview
Table 59. Wellstat Vaccines LLC B Streptococcus (GBS) Infection Treatment Product
Table 60. Wellstat Vaccines LLC Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 61. Wellstat Vaccines LLC Recent Development
Table 62. Minervax ApS Company Detail
Table 63. Minervax ApS Business Overview
Table 64. Minervax ApS B Streptococcus (GBS) Infection Treatment Product
Table 65. Minervax ApS Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 66. Minervax ApS Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis B Streptococcus (GBS) Infection Treatment Product
Table 70. Novartis Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. GlaxoSmithKline Company Detail
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline B Streptococcus (GBS) Infection Treatment Product
Table 75. GlaxoSmithKline Revenue in B Streptococcus (GBS) Infection Treatment Business (2018-2023) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B Streptococcus (GBS) Infection Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global B Streptococcus (GBS) Infection Treatment Market Share by Type: 2022 VS 2033
Figure 3. Prenatal-onset GBS Disease Features
Figure 4. Early-onset GBS Disease Features
Figure 5. Late-onset GBS Disease Features
Figure 6. Global B Streptococcus (GBS) Infection Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global B Streptococcus (GBS) Infection Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. B Streptococcus (GBS) Infection Treatment Report Years Considered
Figure 12. Global B Streptococcus (GBS) Infection Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global B Streptococcus (GBS) Infection Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global B Streptococcus (GBS) Infection Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global B Streptococcus (GBS) Infection Treatment Market Share by Players in 2022
Figure 16. Global Top B Streptococcus (GBS) Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Streptococcus (GBS) Infection Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by B Streptococcus (GBS) Infection Treatment Revenue in 2022
Figure 18. North America B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America B Streptococcus (GBS) Infection Treatment Market Share by Country (2018-2033)
Figure 20. United States B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe B Streptococcus (GBS) Infection Treatment Market Share by Country (2018-2033)
Figure 24. Germany B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific B Streptococcus (GBS) Infection Treatment Market Share by Region (2018-2033)
Figure 32. China B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America B Streptococcus (GBS) Infection Treatment Market Share by Country (2018-2033)
Figure 40. Mexico B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa B Streptococcus (GBS) Infection Treatment Market Share by Country (2018-2033)
Figure 44. Turkey B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia B Streptococcus (GBS) Infection Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Pfizer Inc. Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 47. Alopexx Pharmaceuticals, LLC Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 48. Wellstat Vaccines LLC Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 49. Minervax ApS Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 51. GlaxoSmithKline Revenue Growth Rate in B Streptococcus (GBS) Infection Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed